Christopher W. Ryan
Impact in
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 28
- Prostate Cancer Treatment and Research 25
- Sarcoma Diagnosis and Treatment 24
- Oncology 25
- Cancer Immunotherapy and Biomarkers 13
- Bone health and treatments 4
- Cancer survivorship and care 4
- Co-authors
- Tomasz M. Beer (32 shared papers)Margaret von Mehren (5 shared papers)George D. Demetri (5 shared papers)Cathryn J. Rankin (4 shared papers)Ernest C. Borden (4 shared papers)Charles David Blanke (12 shared papers)Walter Michael Stadler (14 shared papers)Vivien H. C. Bramwell (3 shared papers)
- Journals
- Cancer (16 papers)Journal of Clinical Oncology (12 papers)Clinical Cancer Research (10 papers)The Journal of Urology (7 papers)Clinical Genitourinary Cancer (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Christopher W. Ryan
119 papers receiving 7k citations
Christopher W. Ryan's Hit Papers
Peers
Comparison fields: 5 of 104
- Gastroenterology 1.2k
- Pulmonary and Respiratory Medicine 3k
- Oncology 1k
- Pathology and Forensic Medicine 313
- Cancer Research 230
Countries citing papers authored by Christopher W. Ryan
This map shows the geographic impact of Christopher W. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Ryan more than expected).
Fields of papers citing papers by Christopher W. Ryan
This network shows the impact of papers produced by Christopher W. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Ryan. The network helps show where Christopher W. Ryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher W. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 Hit paper breakdown → | 2008 | 865 |
| 2 | Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group Hit paper breakdown → | 2008 | 494 |
| 3 | Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial Hit paper breakdown → | 2019 | 368 |
| 4 | Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial Hit paper breakdown → | 2016 | 361 |
| 5 | 2020 | 269 | |
| 6 | 2007 | 259 | |
| 7 | 2017 | 243 | |
| 8 | 2010 | 219 | |
| 9 | 2019 | 203 | |
| 10 | 2014 | 195 | |
| 11 | 2016 | 160 | |
| 12 | 2011 | 159 | |
| 13 | 2007 | 126 | |
| 14 | 2003 | 119 | |
| 15 | 2006 | 108 | |
| 16 | 2014 | 104 | |
| 17 | 2008 | 100 | |
| 18 | 2005 | 99 | |
| 19 | 1998 | 98 | |
| 20 | 2011 | 95 |
About Christopher W. Ryan
Christopher W. Ryan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Gastroenterology, Orthopedics and Sports Medicine and Surgery, having authored 123 papers that have together received 7.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (28 papers), Prostate Cancer Treatment and Research (25 papers), Sarcoma Diagnosis and Treatment (24 papers), Cancer Immunotherapy and Biomarkers (13 papers), Bladder and Urothelial Cancer Treatments (4 papers), Bone health and treatments (4 papers), Cancer survivorship and care (4 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Pulmonary and Respiratory Medicine (3k citations), Oncology (1k citations), Pathology and Forensic Medicine (313 citations) and Cancer Research (230 citations). Christopher W. Ryan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Tomasz M. Beer, Margaret von Mehren, George D. Demetri, Cathryn J. Rankin, Ernest C. Borden, Charles David Blanke, Walter Michael Stadler, Vivien H. C. Bramwell, Robert S. Benjamin and Michael Charles Heinrich. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Clinical Cancer Research, The Journal of Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.